Standard vs. lower dose dialysis for kidney failure in intensive care
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in intensive care with sudden kidney failure that needs dialysis.
- You are not already on long-term dialysis for chronic kidney disease.
- You do not have severe liver disease (Child-Pugh C).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of changing the filter in the dialysis machine for people with severe acute kidney injury in the intensive care unit. It looks at whether changing the filter more often (standard) is better or worse than leaving it in longer (shorter filter lifespan).
This study tests a special blood-filtering treatment for patients in the intensive care unit (ICU) with acute kidney injury. It uses a medicine called citrate to prevent blood clotting during dialysis, which may be safer for patients whose liver cannot process citrate normally.
This study compares two different doses of continuous kidney replacement therapy (CRRT, a type of dialysis) for patients in the intensive care unit with acute kidney injury. It aims to find out if a lower dose is as safe and effective as the standard dose.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This study looks at how continuous renal replacement therapy (a type of dialysis) is used in intensive care unit (ICU) patients. Participation will help doctors understand how to better support kidney function in critically ill people.
This study looks at how long patients with serious illness stay in the intensive care unit when they receive a type of kidney treatment called continuous renal replacement therapy (CRRT). It may help doctors understand the impact of this treatment on recovery time.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.